Tellius

Tellius at a Glance

Tellius is an AI-driven decision intelligence platform that pairs natural-language search with automated insights so business users can investigate data without writing SQL or waiting on an analytics team. Founded in 2015 and headquartered in Herndon, Virginia, the company sits in a different lane from dashboard-first tools like Tableau or Microsoft Power BI. Instead of asking users to build their own visualisations, Tellius runs root-cause analysis, anomaly detection, key driver identification, and cohort comparisons on its own and surfaces written narratives explaining what changed and why.

The platform is built around three pillars: search-based BI for ad hoc questions, automated insights for behind-the-scenes discovery, and AutoML for predictive modelling. A newer agent called Kaiya monitors data on a schedule, investigates anomalies as they appear, and delivers finished briefs to stakeholders without anyone opening a dashboard. Pricing is quote-only on both the Premium and Enterprise tiers, which puts Tellius firmly in the enterprise-procurement category rather than the self-serve trial market.

Who Should Use Tellius

The customer roster makes the target market obvious. Tellius lists Novo Nordisk, AbbVie (via Pharmacyclics), Novartis, Regeneron, Genentech, Bristol Myers Squibb, Biogen, and MilliporeSigma on its customers page, which is one of the densest life-sciences logo walls in the analytics space. Pharma commercial teams use it to investigate brand performance, HCP engagement, and patient journey data. Outside of pharma, PepsiCo, eBay, HCA Healthcare, and Pelmorex round out the public references.

That concentration matters. If you sell into pharma, work in clinical operations, or run commercial analytics on IQVIA, Veeva, or MMIT data, Tellius has prebuilt connectors and a sales team that speaks the vocabulary. If you are a generalist mid-market team comparing options against Looker Studio or Metabase, you are probably outside the sweet spot and the price point will reflect that.

Tellius Product Suite

Tellius separates itself from traditional business intelligence tools by automating the analyst workflow rather than just visualising results. The capabilities below are what the platform actually does end to end.

The platform is a single product rather than a suite. There are no separate purchases for data prep, modelling, or visualisation, which keeps the deployment model simpler than competitors like MicroStrategy or IBM Cognos Analytics.

The Kaiya AI Agent

Kaiya is the feature Tellius is currently marketing hardest. It runs as an autonomous agent rather than a chatbot. The agent monitors specified metrics or data sets, detects changes, runs its own follow-up analysis to figure out why a number moved, and then writes the finding into a scheduled brief or alert. This is closer to what a junior analyst does on a Monday morning than what a typical BI dashboard does.

For pharma commercial teams tracking weekly brand performance, this is the headline use case. Instead of an analyst spending two days reconciling movement in scripts or HCP engagement, Kaiya runs the investigation overnight and delivers the answer. Vendor metrics claim 16x faster insight delivery and 185+ hours saved per user per year, which directionally tracks with what teams report when they replace manual reporting cycles with automated agents. Treat the specific numbers as marketing claims rather than independently audited figures.

Integrations and Data Sources

Tellius connects to the systems pharma and enterprise teams actually run on. Confirmed integrations include Snowflake as the primary cloud warehouse, Salesforce for CRM data, Gong for revenue conversation data, SAP for enterprise finance, Excel for ad hoc uploads, SharePoint for document-level data, and Anaplan for planning workflows.

The pharma-specific connectors are where Tellius pulls ahead of generalist platforms. IQVIA for prescriber and patient data, Veeva for CRM and content management, and MMIT for managed-markets access data are all natively supported. Teams running Sigma Computing or Holistics on top of Snowflake would have to build these pipelines themselves.

Deployment, Security, and Architecture

Tellius supports three deployment models on the Enterprise tier: Tellius Cloud as a managed SaaS, customer-managed cloud where the platform runs inside the buyer's AWS or Azure tenant, and on-premises for regulated environments. The on-prem option is meaningful for pharma customers who have data residency or regulatory constraints that block standard SaaS deployment.

On the security side, Enterprise customers get SAML single sign-on and API access for programmatic control. White-labelling is also available for partners embedding Tellius into their own products. One honest caveat: the vendor's /security and /trust pages return 404 at the time of this writing, so independent buyers cannot self-serve compliance documentation. SOC 2, HIPAA, and GDPR attestations are not published on the public site. If your procurement process requires these on file, request them directly from Tellius sales and confirm before signing.

How Much Does Tellius Cost

Tellius publishes two tiers on its pricing page, both marked as "Customized" with no list price. Third-party aggregators report a $495 per month starting figure, but the vendor itself does not publish that number, so it should not be treated as authoritative.

Opaque pricing is the norm in this segment. Sisense, QlikView, and most enterprise-tier analytics platforms operate the same way. The trade-off is that you cannot benchmark cost without a sales call, which adds friction for teams in an early evaluation stage. If transparent per-user pricing is non-negotiable, Zoho Analytics or Amazon QuickSight publish their rate cards openly.

Hidden Costs and Contract Gotchas

Tellius price quotes are negotiated, so the line items that drive total cost matter more than headline numbers:

• Compute consumption. Kaiya AI queries and large search-based explorations run on Tellius cloud or your dedicated cluster; consumption climbs with active-user count, not seat count.
• On-prem footprint. Self-hosted Tellius needs Kubernetes plus a sized data plane; expect $40,000 to $80,000 of internal infra cost per year for a 200-user deployment.
• LLM token spend. Bring-your-own OpenAI or Azure OpenAI keys can rack up token costs separately from the Tellius bill once Kaiya is opened to business users.
• Three-year commit. Standard enterprise terms are three years with annual uplifts of 5% to 8%; ask for a cap.

Implementation Plan: Rolling Out Tellius

A typical Tellius rollout for a 200 to 500-user organization runs 10 to 16 weeks:

• Weeks 1 to 2: discovery and architecture. Decide between SaaS and self-hosted, define data sources, scope Kaiya use cases.
• Weeks 3 to 5: data ingestion and modeling. Connect Snowflake, BigQuery, or Redshift; build the semantic layer that Kaiya queries against.
• Weeks 6 to 9: search and dashboard build. Configure Search Analytics, design starter dashboards, set row-level security.
• Weeks 10 to 13: Kaiya tuning and UAT. Train Kaiya prompts against governed metrics, run UAT with business users.
• Weeks 14 to 16: training and phased go-live. Train champions in each department, then roll out by team.

What Real Buyers Report

Public review coverage of Tellius is thin compared to the major dashboard tools. Gartner Peer Insights shows a 4.7 out of 5 average across 71 reviews, which is the most substantial third-party signal available. Capterra has the product listed but no reviews yet, and G2's page returns a 403 at the time of writing, so the broader review aggregators have not built up the volume you would see for a Tableau or Power BI.

That thin coverage is consistent with an enterprise-sales platform whose customers tend to be large pharma and Fortune 500 buyers rather than self-serve teams who leave public reviews. Vendor-reported metrics include a 97% recommendation rate, 16x faster insights, 185+ hours saved per user per year, and $100M+ in bottom-line impact across the customer base. Read those as vendor claims and validate against reference calls during evaluation.

Pros and Cons of Tellius

Strengths

• Pharma vertical fit is genuinely strong with native IQVIA, Veeva, and MMIT connectors plus a customer list dense with life-sciences names
• Automated insights and Kaiya agent reduce the analyst-hours required for routine investigation and recurring reporting
• Three deployment models including on-prem accommodate regulated industries that cannot use standard SaaS
• Single integrated platform avoids the multi-product procurement complexity of legacy enterprise BI suites
• 4.7 average across 71 Gartner Peer Insights reviews indicates real customer satisfaction even if volume is modest

Weaknesses

• Both pricing tiers are quote-only with no published list price, which slows early-stage evaluation
• Public compliance documentation is missing because the vendor's /security and /trust pages return 404, forcing buyers to request attestations through sales
• G2 page returns a 403 and Capterra has zero reviews, so independent review coverage is limited
• Mobile app status is not confirmed on the vendor site
• Outside pharma and a handful of large enterprises like PepsiCo and HCA, the public customer base is narrow

Tellius Alternatives

Tellius is not a like-for-like swap for general-purpose BI tools. Domo and Power BI are dashboard-first platforms where humans build the views. Tellius automates the discovery itself and writes the narrative. For teams whose pain is "we have dashboards but nobody knows why the number moved," Tellius solves a problem that dashboard tools do not address.

Against direct competitors in augmented analytics, Tellius's pharma vertical depth is the differentiator. Sisense and ThoughtSpot compete on similar search-based BI ground, but neither has the same density of life-sciences customers or the prebuilt IQVIA and Veeva connectors. For non-pharma buyers, Redash may be a closer fit depending on whether the priority is SQL-native exploration or guided self-service.

Bottom Line

Tellius is a serious option if you run analytics for a pharma commercial team, life-sciences company, or large enterprise where automated insight generation and on-prem deployment matter more than dashboard polish or self-serve pricing. The customer roster, the Kaiya agent, and the IQVIA-Veeva-MMIT integrations are the reasons buyers in that profile pick it over generalist BI tools. Outside that profile, the quote-only pricing and missing public compliance pages make it harder to evaluate than alternatives with published pricing and trust centres. Get on a sales call early, request SOC 2 and HIPAA documentation in writing, and pressure-test the vendor claims against two or three reference customers in your industry before committing.